UR Home
![]() | Up a level |
, Hüttmann, Andreas, Noppeney, Richard, Müller-Tidow, Carsten, Krug, Utz, Baldus, Claudia D, Brandts, Christian H
, Kunzmann, Volker, Einsele, Hermann, Krämer, Alwin, Schäfer-Eckart, Kerstin, Neubauer, Andreas, Burchert, Andreas, Giagounidis, Aristoteles, Krause, Stefan W
, Mackensen, Andreas, Aulitzky, Walter, Herbst, Regina, Hänel, Mathias, Kiani, Alexander, Frickhofen, Norbert, Kullmer, Johannes, Kaiser, Ulrich, Link, Hartmut, Geer, Thomas, Reichle, Albert, Junghanß, Christian, Repp, Roland, Heits, Frank, Dürk, Heinz, Hase, Jana, Klut, Ina-Maria, Illmer, Thomas, Bornhäuser, Martin, Schaich, Markus, Parmentier, Stefani, Görner, Martin, Thiede, Christian
, von Bonin, Malte, Schetelig, Johannes, Kramer, Michael, Berdel, Wolfgang E and Ehninger, Gerhard
(2015)
Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial.
The Lancet Oncology 16 (16), pp. 1691-1699.
Fulltext not available.
, Markova, Jana, Sasse, Stephanie, Fuchs, Michael, Topp, Max S, Soekler, Martin, Mathas, Stephan, Meissner, Julia, Wilhelm, Martin, Koch, Peter, Lindemann, Hans-Walter, Schalk, Enrico, Semrau, Robert, Kriz, Jan, Vieler, Tom, Bentz, Martin, Lange, Elisabeth, Mahlberg, Rolf, Hassler, Andre, Vogelhuber, Martin, Hahn, Dennis, Mezger, Jörg, Krause, Stefan W
, Skoetz, Nicole, Böll, Boris, von Tresckow, Bastian, Diehl, Volker, Hallek, Michael, Borchmann, Peter, Stein, Harald, Eich, Hans and Engert, Andreas
(2015)
Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial.
The Lancet 385 (9976), pp. 1418-1427.
Fulltext not available.
, Gebhard, Claudia, Schwarzfischer, Lucia, Krause, Stefan W
, Andreesen, Reinhard and Rehli, Michael
(2010)
Active DNA demethylation in human postmitotic cells correlates with activating histone modifications, but not transcription levels.
Genome Biology 11 (6).
Fulltext not available.
, Krause, Stefan W
, Schölmerich, Jürgen and Fleck, Martin
(2003)
The JAM-assay: optimized conditions to determine death-receptor-mediated apoptosis.
Methods 31 (2), pp. 127-134.
Fulltext not available.
Publication Server
Publishing: oa@ur.de
0941 943 -4239 or -69394
Dissertations: dissertationen@ur.de
0941 943 -3904
Research data: datahub@ur.de
0941 943 -5707